Sanofi, poised to rival Roche in hemophilia, nabs FDA approval for Altuviiio

Sanofi and partner Sobi are coming back to the hemophilia A market with a vengeance after Roche’s Hemlibra ate up sales of their aging Eloctate. | Sanofi and partner Sobi are coming back to the hemophilia A market with a vengeance after Roche’s Hemlibra ate up sales of their aging Eloctate. The…#rocheshemlibra #eloctate #altuviiio
Source: Reuters: Health - Category: Consumer Health News Source Type: news